Czechia, July 23 -- Czechia based PROMEDICA PRAHA GROUP, a.s has secured contract from Revmatologicky ustav for Antineoplastic and immunomodulating agents - Drug deliveries - REMSIMA II 2026 . The value of the contract is worth 56164000 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....